Laboratório Químico Farmacêutico Bergamo Ltda.   Report issue

For profit Phase 3
Founded: Taboão da Serra Brazil (2005)
Status: Acquired by Amgen (2012)

Organization Overview

First Clinical Trial
2011
NCT01180348
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Laboratoio Quimico Farmaceutico Bergamo